NantOmics to Present Data on Using GPS Cancer Quantitative Proteomic Analysis of Class III B-Tubulin (TUBB3) to Predict Survival in Gastric Cancer Patients Randomized to Docetaxel at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting